Correction: Consensus Statement: Recommendations on Actionable Biomarker Testing for Thyroid Cancer Management

Correction: Endocrine Pathology

10.1007/s12022-024-09836-x

In this article, the citation of Table 1 in the first paragraph of section "Constitutional (Germline) Testing in Patients Diagnosed with Non‑Anaplastic Follicular Cell‑Derived Thyroid Cancer" should have been Table 2. The sentence should read "Constitutional testing is also necessary for those with syndromic manifestations suspicious for other hereditary cancer syndromes not included above or in Table 2 [9, 32, 60, 61] (Fig. 2)."

The original article has been corrected.